4th Circ. Denies Eli Lilly's Discovery Bid In Novartis IP Feud

By Jasmin Boyce (June 16, 2022, 8:53 PM EDT) -- The Fourth Circuit on Thursday affirmed a Virginia district court's decision denying Eli Lilly's discovery bid related to Novartis' European patent suit over Eli Lilly's psoriasis drug Taltz, agreeing that Novartis didn't reside in the district and thus couldn't be forced to hand over evidence for use in foreign proceedings....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!